Exosome-loaded hydrogels for craniofacial bone tissue regeneration.
Guanying LiuChang LiuQingquan LinTing ShiGuanying LiuPublished in: Biomedical materials (Bristol, England) (2024)
It is common for maladies and trauma to cause significant bone deterioration in the craniofacial bone, which can cause patients to experience complications with their appearance and their ability to function. Regarding grafting procedures' complications and disadvantages, the newly emerging field of tissue regeneration has shown promise. Tissue -engineered technologies and their applications in the craniofacial region are increasingly gaining prominence with limited postoperative risk and cost. MSCs-derived exosomes are widely applied in bone tissue engineering to provide cell-free therapies since they not only do not cause immunological rejection in the same way that cells do, but they can also perform a cell-like role. Additionally, the hydrogel system is a family of multipurpose platforms made of cross-linked polymers with considerable water content, outstanding biocompatibility, and tunable physiochemical properties for the efficient delivery of commodities. Therefore, the promising exosome-loaded hydrogels can be designed for craniofacial bone regeneration. This review lists the packaging techniques for exosomes and hydrogel and discusses the development of a biocompatible hydrogel system and its potential for exosome continuous delivery for craniofacial bone healing.
Keyphrases
- tissue engineering
- bone regeneration
- drug delivery
- wound healing
- bone mineral density
- stem cells
- mesenchymal stem cells
- cell free
- hyaluronic acid
- bone loss
- soft tissue
- end stage renal disease
- drug release
- cancer therapy
- induced apoptosis
- chronic kidney disease
- postmenopausal women
- cell proliferation
- single cell
- ejection fraction
- signaling pathway
- cell therapy
- machine learning
- oxidative stress